Clinical trial

A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

NCT01175811

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-02-01

PhasePHASE4

Study timeline

Study start (unknown)2011-02-01Date precision: month

Registry last updated2013-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Insulin Lispro PremixDRUG

Insulin GlargineDRUG · verified · RxNorm: insulin glargine

Insulin LisproDRUG · verified · RxNorm: insulin lispro

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

SeoulSouth Korea1 BeijingChina1 ShanghaiChina1 GuangzhouChina1 DaeguSouth Korea1 NanjingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01175811 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.